LATE-BREAKING ABSTRACT: Intravenous infusion of Chinese medicine xuebijing significantly improved clinical outcome in severe pneumonia patients in a multiple center randomized controlled clinical trials

Yuanlin Song (Shanghai, China), Yuanlin Song, Chen Yao, Hongcai Shang, Xiaoqing Yao, Chunxue Bai

Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yuanlin Song (Shanghai, China), Yuanlin Song, Chen Yao, Hongcai Shang, Xiaoqing Yao, Chunxue Bai. LATE-BREAKING ABSTRACT: Intravenous infusion of Chinese medicine xuebijing significantly improved clinical outcome in severe pneumonia patients in a multiple center randomized controlled clinical trials. Eur Respir J 2016; 48: Suppl. 60, 3323

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015



Late Breaking Abstract - Adjunctive treatment with oral dexamethasone in adults hospitalised with community-acquired pneumonia: a randomised clinical trial
Source: Virtual Congress 2020 – ALERT: Infection in adults and children
Year: 2020




LATE-BREAKING ABSTRACT: Home nutritional rehabilitation improves survival in malnourished patients with chronic respiratory failure: a randomised controlled trial
Source: Annual Congress 2009 - Exploring outcome measures in COPD and pulmonary rehabilitation
Year: 2009

Tele-assistance in chronic respiratory failure patients: a randomised clinical trial
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008


LATE-BREAKING ABSTRACT: Prospective randomised pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in patients after primary lung transplantation (LuTX)
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015


Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Source: Eur Respir J, 56 (6) 2002808; 10.1183/13993003.02808-2020
Year: 2020



Levodropropizine effect on respiratory centre output, a randomized clinical trial
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016


Time-to-treatment failure in the Belgian randomized controlled trial with azithromycin for acute COPD exacerbations requiring hospitalization
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016


Efficacy and safety of isoproterenol continuous inhalation treatment for acute severe exacerbation of asthma in children; a randomized, double-blind controlled study
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial
Source: Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020
Year: 2021



Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021



Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011


Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
Source: Virtual Congress 2021 – ALERT: COPD
Year: 2021



Effect of excluding ICU-admission on clinical outcomes in a randomized control trial studying the effect of corticosteroids in patients hospitalized with CAP
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012

Salutary effect of fructose-1,6-diphosphate in lung injury: a randomized double-blinded placebo clinical trial
Source: Annual Congress 2007 - Lung recruitment
Year: 2007


Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019
Year: 2020



High-Flow Oxygen Therapy (HFOT) during training in COPD with chronic respiratory failure (CRF): a multicentre randomized controlled trial
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019




RCT Abstract - An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19
Source: Virtual Congress 2021 – ALERT: bronchiectasis and COVID
Year: 2021



LATE-BREAKING ABSTRACT: A randomised controlled trial comparing stepwise versus immediate withdrawal from non-invasive ventilation in chronic obstructive pulmonary disease patients recovering from acute hypercapnic respiratory failure
Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts
Year: 2012


Noninvasive ventilation for treating acute hypercapnic respiratory failure in elderly patients: a randomized controlled trial
Source: Eur Respir J 2003; 22: Suppl. 45, 402s
Year: 2003